Intech Investment Management LLC Has $3.38 Million Holdings in The Clorox Company (NYSE:CLX)

Intech Investment Management LLC cut its position in The Clorox Company (NYSE:CLX) by 34.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,755 shares of the company’s stock after selling 12,871 shares during the quarter. Intech Investment Management LLC’s holdings in Clorox were worth $3,378,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. SG Americas Securities LLC grew its position in Clorox by 1,525.7% in the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock worth $10,046,000 after purchasing an additional 61,576 shares during the last quarter. Mizuho Markets Americas LLC grew its position in Clorox by 93.7% in the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after purchasing an additional 34,864 shares during the last quarter. CANADA LIFE ASSURANCE Co grew its position in Clorox by 15.2% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock worth $21,705,000 after purchasing an additional 18,687 shares during the last quarter. Advisors Asset Management Inc. grew its position in Clorox by 257.5% in the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock worth $1,719,000 after purchasing an additional 8,087 shares during the last quarter. Finally, Game Plan Financial Advisors LLC acquired a new stake in Clorox in the 1st quarter worth $1,025,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.51% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the subject of a number of analyst reports. BNP Paribas raised shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Barclays lifted their price target on shares of Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a report on Monday, August 5th. JPMorgan Chase & Co. cut their price target on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. Wells Fargo & Company cut their price target on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. Finally, TD Cowen started coverage on shares of Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 target price for the company. Six research analysts have rated the stock with a sell rating and twelve have given a hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $143.33.

Clorox Stock Performance

Shares of CLX stock opened at $163.33 on Monday. The company’s fifty day simple moving average is $149.14 and its 200-day simple moving average is $143.69. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The firm has a market cap of $20.28 billion, a PE ratio of 84.63, a P/E/G ratio of 3.29 and a beta of 0.40. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.09.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Equities research analysts expect that The Clorox Company will post 6.63 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 2.99%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is currently 252.85%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.